Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shield Biotech

Shield Biotech
2013 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of medicinal products designed to offer treatment for breast cancer vaccine. The company's products include a vaccine for the prevention of recurrence of breast cancer and offer preclinical development to seek permission from the medical authorities to test the vaccine as an investigational new drug in proof-of-concept and first-in-human trials, enabling healthcare professionals to deliver advanced medicines for their patients that helps them to recover faster.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 10000 Cedar Avenue
  • Cleveland, OH 44106
  • United States

+1 (216) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shield Biotech’s full profile, request a free trial.

Shield Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Early Stage VC (Series A) 06-Sep-2013 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Shield Biotech Executive Team (2)

Name Title Board
Seat
Contact
Info
Jeffrey Marshall Chief Executive Officer and President
Vincent Tuohy Ph.D Chief Scientific Officer